Alsip N L, Schuschke D A, Miller F N
Center for Applied Microcirculatory Research and the Department of Physiology, University of Louisville, KY 40292, USA.
J Lab Clin Med. 1996 Oct;128(4):429-37. doi: 10.1016/s0022-2143(96)80016-3.
We examined microvascular responses to acetylcholine (ACh), adenosine (ADO), nitroprusside (SNP), bradykinin (BK), histamine (HIS), and serotonin (5-HT) in control and diabetic rats. Agonists were applied topically to neurovascularly intact and environmentally controlled cremaster muscles of diabetic or control rats 3 weeks after streptozotocin or vehicle injection. Precapillary arteriolar diameters and leakage of fluorescein isothiocyanate conjugated to bovine serum albumin (FITC-BSA) in postcapillary venules were measured by using intravital microscopy techniques. All agents dilated the arterioles, and BK, HIS, and 5-HT caused concentration-dependent leakage of FITC-BSA. Of the vasodilators tested, only ACh-induced dilation was attenuated in diabetic animals. BK and HIS caused a concentration-dependent leakage of FITC-BSA that was similar in diabetic and control groups, but FITC-BSA leakage to 5-HT was significantly attenuated in diabetic animals. To determine whether the attenuated responses were attributable to an alteration of nitric oxide, the same dilational and leakage-promoting agents were tested in normoglycemic animals in the presence of N'-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide synthase. Only ACh-induced dilation in control animals was attenuated in the presence of L-NAME; all other responses were normal. Thus, although the attenuated ACh-induced arteriolar dilation in striated muscle of diabetic rats may be linked to an impairment of nitric oxide function or release, the reduced leakage to serotonin is not linked to nitric oxide. The impaired leakage response to 5-HT is specific for that agonist and is not an indication of a generalized decrease in vascular permeability in these diabetic animals.
我们研究了正常大鼠和糖尿病大鼠对乙酰胆碱(ACh)、腺苷(ADO)、硝普钠(SNP)、缓激肽(BK)、组胺(HIS)和5-羟色胺(5-HT)的微血管反应。在链脲佐菌素或赋形剂注射3周后,将激动剂局部应用于糖尿病或正常大鼠神经血管完整且环境可控的提睾肌。采用活体显微镜技术测量毛细血管前小动脉直径以及毛细血管后微静脉中异硫氰酸荧光素偶联牛血清白蛋白(FITC-BSA)的渗漏情况。所有药物均使小动脉扩张,BK、HIS和5-HT导致FITC-BSA呈浓度依赖性渗漏。在所测试的血管扩张剂中,只有糖尿病动物中ACh诱导的扩张减弱。BK和HIS导致FITC-BSA呈浓度依赖性渗漏,糖尿病组和正常组相似,但糖尿病动物中FITC-BSA对5-HT的渗漏显著减弱。为了确定反应减弱是否归因于一氧化氮的改变,在存在一氧化氮合酶抑制剂N'-硝基-L-精氨酸甲酯(L-NAME)的情况下,对血糖正常的动物测试相同的扩张和促进渗漏药物。仅在L-NAME存在时,正常动物中ACh诱导的扩张减弱;所有其他反应均正常。因此,尽管糖尿病大鼠横纹肌中ACh诱导的小动脉扩张减弱可能与一氧化氮功能或释放受损有关,但5-HT导致的渗漏减少与一氧化氮无关。对5-HT的渗漏反应受损是该激动剂特有的,并非这些糖尿病动物血管通透性普遍降低的迹象。